Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -48,169 | -49,048 | -613 | -74,874 | -50,122 |
| Depreciation Amortization | 46,357 | 50 | 101 | 201 | 192 |
| Income taxes - deferred | N/A | -13,582 | -6,880 | -29,413 | -15,267 |
| Accounts receivable | -644 | N/A | N/A | 11 | N/A |
| Other Working Capital | 287 | 117 | 682 | -2,085 | 1,679 |
| Other Operating Activity | 606 | 54,173 | -193 | 91,505 | 53,201 |
| Operating Cash Flow | $-1,563 | $-8,290 | $-6,903 | $-14,655 | $-10,317 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -145 | -28 | -40 | -51 | -339 |
| Other Investing Activity | 0 | 1,400 | 0 | 54 | 77 |
| Investing Cash Flow | $-145 | $1,372 | $-40 | $3 | $-262 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,000 | 1,000 | N/A | N/A |
| Common Stock Issued | 6,638 | 7,912 | 3,080 | 9,016 | 15,885 |
| Other Financing Activity | -214 | -19 | 0 | 0 | 0 |
| Financing Cash Flow | $6,424 | $8,893 | $4,080 | $9,016 | $15,885 |
| Beginning Cash Position | 2,752 | 777 | 3,640 | 9,276 | 3,970 |
| End Cash Position | 7,468 | 2,752 | 777 | 3,640 | 9,276 |
| Net Cash Flow | $4,716 | $1,975 | $-2,863 | $-5,636 | $5,306 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,563 | -8,290 | -6,903 | -14,655 | -10,317 |
| Capital Expenditure | -145 | -28 | -40 | -51 | -339 |
| Free Cash Flow | -1,708 | -8,318 | -6,943 | -14,706 | -10,656 |